Recombinant Candida rugosa lipases
    202.
    发明授权
    Recombinant Candida rugosa lipases 有权
    重组念珠菌多脂脂肪酶

    公开(公告)号:US07468429B2

    公开(公告)日:2008-12-23

    申请号:US11349592

    申请日:2006-02-07

    CPC classification number: C12N9/20 C07K2319/00

    Abstract: The present invention features an isolated nucleic acid that includes a mutant DNA encoding a Candida rugosa lipase, wherein the mutant DNA is 80% identical to a wild-type DNA encoding the Candida rugosa lipase, and includes at least 12 (e.g., 13, 15, 17, or all) universal serine codons corresponding to CTG codons in the wild-type DNA. Each of the universal serine codons, independently, is TCT, TCC, TCA, TCG, AGT, or AGC. The Candida rugosa lipase can be Candida rugosa lipase 1, 2, 3, 4, 5, or 8.

    Abstract translation: 本发明的特征在于分离的核酸,其包含编码假丝酵母假单胞菌脂肪酶的突变DNA,其中突变DNA与编码假丝酵母脂肪酶的野生型DNA具有80%同一性,并且包括至少12个(例如13,15 ,17或全部)对应于野生型DNA中的CTG密码子的通用丝氨酸密码子。 每个通用丝氨酸密码子独立地是TCT,TCC,TCA,TCG,AGT或AGC。 假丝酵母粗脂肪酶可以是1号,2号,3号,4号,5号或8号念珠菌。

    Method for characterizing transparent thin-films using differential optical sectioning interference microscopy
    204.
    发明申请
    Method for characterizing transparent thin-films using differential optical sectioning interference microscopy 失效
    使用差分光学切片干涉显微镜表征透明薄膜的方法

    公开(公告)号:US20080266548A1

    公开(公告)日:2008-10-30

    申请号:US11789769

    申请日:2007-04-25

    Abstract: An imaging, differential optical sectioning interference microscopy (DOSIM) system and method for measuring refractive indices and thicknesses of transparent thin-films. The refractive index and thickness are calculated from two interferometric images of the sample transparent thin-film having a vertical offset that falls within the linear region of an axial response curve of optically sectioning microscopy. Here, the images are formed by a microscope objective in the normal direction, i.e., in the direction perpendicular to the latitudinal surface of the thin-film. As a result, the lateral resolution of the transparent thin-film is estimated based on the Rayleigh criterion, 0.61λ/NA.

    Abstract translation: 用于测量透明薄膜的折射率和厚度的成像,差分光学切片干涉显微镜(DOSIM)系统和方法。 折射率和厚度由具有落在光学切片显微镜的轴向响应曲线的线性区域内的垂直偏移的样品透明薄膜的两个干涉图像计算。 这里,图像由显微镜物镜沿正交方向,即在与薄膜的纬向表面垂直的方向上形成。 结果,透明薄膜的横向分辨率基于Rayleigh标准估计,为0.61λ/ NA。

    PROTEIN ISOLATION
    207.
    发明申请
    PROTEIN ISOLATION 有权
    蛋白质分离

    公开(公告)号:US20080125576A1

    公开(公告)日:2008-05-29

    申请号:US11873241

    申请日:2007-10-16

    Abstract: A fusion protein containing a polyhedrin of a virus and a foreign polypeptide sequence. Also disclosed are a recombinant occlusion body containing the fusion protein, an isolated nucleic acid containing a sequence encoding the fusion protein, and a recombinant virus containing the nucleic acid. Within the scope of this invention are related expression vectors, host cells, compositions, and preparation methods.

    Abstract translation: 含有病毒多角体蛋白和外来多肽序列的融合蛋白。 还公开了含有融合蛋白的重组闭塞体,含有编码融合蛋白的序列的分离的核酸和含有核酸的重组病毒。 在本发明的范围内是相关的表达载体,宿主细胞,组合物和制备方法。

    Certain lithocholic acid analogues that inhibit sialyltransferase
    208.
    发明申请
    Certain lithocholic acid analogues that inhibit sialyltransferase 有权
    抑制唾液酸转移酶的某些石胆酸类似物

    公开(公告)号:US20080119443A1

    公开(公告)日:2008-05-22

    申请号:US11481131

    申请日:2006-07-03

    CPC classification number: C07J1/00 C07J51/00

    Abstract: Certain chemical entities chosen from compounds of Formula I: and pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, and mixtures thereof are described. Pharmaceutical compositions comprising at least one chemical entity chosen from compounds of Formula I and a pharmaceutically acceptable vehicle are described. Also described are methods for inhibiting α-2,3-sialyltransferase activity in cells, and methods for treating a patient having a disease responsive to inhibition of α-2,3-sialyltransferase activity.

    Abstract translation: 描述了选自式I化合物的某些化学实体及其药学上可接受的盐,溶剂化物,螯合物,非共价复合物,前药及其混合物。 描述了包含至少一种选自式I化合物和药学上可接受的载体的化学实体的药物组合物。 还描述了抑制细胞中α-2,3唾液酸转移酶活性的方法,以及用于治疗患有对2,3-唾液酸转移酶活性的抑制有响应的疾病的患者的方法。

Patent Agency Ranking